相关实验视频
Updated: May 21, 2025

08:50
Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
6.8K
免疫瘤生成:一种新的概念,以了解癌症的分子驱动因素
Reshma Sirajee1, Sami El Khatib2,3, Levinus A Dieleman4
1Faculty of Science, 1-001 CCIS, University of Alberta, Edmonton, AB T6G 2E1, Canada.
Journal of clinical medicine
|March 17, 2025
概括
癌症的发展涉及遗传,表观遗传和代谢变化. 这篇评论强调了AMPK,瘦素和RASSF1A等新兴驱动因素,提出了"免疫MET瘤发生"来统一癌症研究中的炎症,新陈代谢和扩散.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 癌症是从复杂的多步骤过程中产生的,包括遗传,表观遗传,突变,炎症和代谢中断.
- 异常的炎症和新陈代谢越来越被认为是恶性表型的重要驱动因素,即使在癌前状态.
研究的目的:
- 审查影响扩散,炎症和新陈代谢的新兴分子元素,作为癌症表型的潜在驱动因素.
- 介绍和定义新的三方概念"免疫MET瘤发生".
主要方法:
- 关于参与癌症发展的信号通路的文献综述.
- 讨论特定的分子参与者,包括AMPK,瘦素,NOD2/RIPK2,TAK1,单碳酸盐输送体 (MCT) 和RASSF1A.
- 开发概念框架,以了解癌症驱动因素.
主要成果:
- 确定了影响扩散,炎症和新陈代谢的关键新兴元素.
- 突出了AMPK,瘦素,NOD2/RIPK2,TAK1,MCT和RASSF1A在致癌中的作用.
- 提出"免疫MET瘤发生"作为这些相互连接的途径的统一术语.
结论:
- 炎症和新陈代谢中的新兴元素是癌症的关键驱动因素.
- 了解扩散,炎症和新陈代谢之间的相互作用对于理解癌症发展至关重要.
- "免疫MET瘤学"的概念为癌症研究和生物标志物开发提供了新的视角.
相关概念视频
Tumor Immunotherapy
454
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
454
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K

